N/A
N=46
Body Awareness Therapy for People With Stroke
Stroke
Bottom Line
View on ClinicalTrials.gov: NCT01613339 ↗Enrolled (actual)
46
Serious AEs
0.0%
Results posted
Dec 2013
Primary outcome: Primary: Bergs Balance Scale — 52.3; 47.8 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Balance training using Body awareness therapy (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Örebro County Council
- Primary completion
- Feb 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Bergs Balance Scale |
52.3; 47.8 | — |
| SECONDARY Timed Up and Go Test |
13.7; 17.6 | — |
| SECONDARY Activities-specific Balance Confidence Scale |
68.6; 59.1 | — |
Summary
Affected balance capacity is common after a stroke due to paresis and sensory disturbances. The affected balance capacity may cause walking disturbances, falls and decreased mobility. Balance may be improved by physical therapy. A possible method for balance training is body awareness therapy, that was introduced in Sweden by Jacques Dropsy and Gertrud Roxendal. Earlier body awareness therapy was mostly used in psychiatric care but in the recent years the method has been used for people with long-tern pain, amputations and multiple sclerosis. Body awareness therapy includes exercises in lying, sitting and standing. Focus of the exercises are awareness of one´s movement behaviour, breathing patterns, resources and limitations. Postural control is an essential part in the exercises. Body awareness therapy could be used for people with stroke as a way to improve postural control. The aim of this study is to investigate if balance training using body awareness therapy can improve balance and walking in people after stroke. The interventions consists of body awareness therapy once a week for 8 weeks.
Eligibility Criteria
Inclusion Criteria
- Diagnosed stroke more than 6 months ago. Walking capacity of 100 meter with or without assistive device.
Exclusion Criteria
- Medical or cognitive impairment that prohibits participating in the intervention.
Data sourced from ClinicalTrials.gov (NCT01613339). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.